We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
-13.22%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.1B
AUM Growth
-$3.31B
(-16%)
Cap. Flow
-$374M
Cap. Flow
% of AUM
-2.19%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
1,420
New
91
Increased
417
Reduced
597
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$69.4M |
| 2 |
Ulta Beauty
ULTA
|
+$54.9M |
| 3 |
Lockheed Martin
LMT
|
+$54M |
| 4 |
Advanced Micro Devices
AMD
|
+$53.7M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$53M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$52.3M |
| 3 |
Take-Two Interactive
TTWO
|
+$47.9M |
| 4 |
eBay
EBAY
|
+$44.3M |
| 5 |
Cardinal Health
CAH
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.22% |
| 2 | Healthcare | 14.4% |
| 3 | Financials | 10.22% |
| 4 | Consumer Discretionary | 8.43% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Thermo Fisher Scientific
TMO
$211B
| $78M | 0.46% |
143,613
+9,230
| +7% | +$5.08M |
|
52
Vanguard Dividend Appreciation ETF
VIG
$111B
| $77.9M | 0.46% |
542,830
+3,462
| +0.6% | +$527K |
|
53
Arista Networks
ANET
$219B
| $77.3M | 0.45% |
3,298,584
-43,792
| -1% | -$1.2M |
|
54
NextEra Energy
NEE
$187B
| $77M | 0.45% |
994,076
+42,030
| +4% | +$3.2M |
|
55
Merck
MRK
$324B
| $74.6M | 0.44% |
818,453
+15,501
| +2% | +$1.37M |
|
56
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $74.3M | 0.44% |
1,821,694
-282,159
| -13% | -$12.5M |
|
57
Applied Materials
AMAT
$426B
| $74.3M | 0.44% |
816,375
-244,640
| -23% | -$26.8M |
|
58
Coca-Cola
KO
$354B
| $73.9M | 0.43% |
1,174,512
-32,184
| -3% | -$2.04M |
|
59
Labcorp
LH
$24.3B
| $73.6M | 0.43% |
365,633
-2,160
| -0.6% | -$460K |
|
60
Honeywell
HON
$77.1B
| $73.2M | 0.43% |
447,110
-5,855
| -1% | -$1.05M |
|
61
Intel
INTC
$466B
| $72.5M | 0.42% |
1,937,348
-65,593
| -3% | -$2.84M |
|
62
TJX Companies
TJX
$170B
| $72M | 0.42% |
1,289,312
-41,781
| -3% | -$2.53M |
|
63
Gartner
IT
$9.41B
| $70.6M | 0.41% |
291,849
+58,629
| +25% | +$15.6M |
|
64
Target
TGT
$62.1B
| $68.6M | 0.4% |
485,638
-89,745
| -16% | -$17.2M |
|
65
United Parcel Service
UPS
$97.6B
| $68.1M | 0.4% |
373,054
-10,233
| -3% | -$1.87M |
|
66
AbbVie
ABBV
$458B
| $68M | 0.4% |
444,209
-4,897
| -1% | -$748K |
|
67
Union Pacific
UNP
$183B
| $65M | 0.38% |
304,737
-4,077
| -1% | -$928K |
|
68
Berkshire Hathaway Class B
BRK.B
$1.07T
| $63.7M | 0.37% |
233,353
-5,803
| -2% | -$1.82M |
|
69
CVS Health
CVS
$137B
| $63.7M | 0.37% |
687,393
-2,400
| -0.3% | -$234K |
|
70
iShares Core S&P 500 ETF
IVV
$876B
| $63.2M | 0.37% |
166,586
+2,298
| +1% | +$945K |
|
|
71
Advanced Micro Devices
AMD
$851B
| $61.8M | 0.36% |
807,646
+573,628
| +245% | +$53.7M |
|
72
Parker-Hannifin
PH
$125B
| $61.3M | 0.36% |
249,074
-8,409
| -3% | -$2.25M |
|
73
Booking.com
BKNG
$138B
| $61.2M | 0.36% |
874,825
-31,275
| -3% | -$2.67M |
|
74
Colgate-Palmolive
CL
$72.6B
| $61.1M | 0.36% |
762,469
-179,800
| -19% | -$14.1M |
|
75
American Tower
AMT
$77.7B
| $60.8M | 0.36% |
237,755
-107,938
| -31% | -$27.1M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q2 2022 Portfolio in Review
As of Q2 2022, Glenmede Trust held 1,420 positions worth $17.1B, down 16% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Glenmede Trust's Q2 2022 filing shows 91 new, 417 increased, 597 reduced and 121 closed positions. Its largest new stake was Pinterest: 974,820 shares worth $17.7M. The largest sale was Accenture, an estimated $53M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Glenmede Trust's largest Q2 2022 buy was Pinterest: 974,820 shares worth $17.7M.
- Glenmede Trust added most to Vanguard Total Stock Market ETF in Q2 2022, an estimated $69.4M increase.
- Glenmede Trust's biggest Q2 2022 reduction was Accenture, cutting an estimated $53M.
- Glenmede Trust fully exited Ovintiv in Q2 2022, selling an estimated $35M.
- Glenmede Trust's ten largest holdings make up 20% of its $17.1B portfolio in Q2 2022.
- Glenmede Trust opened 91 new positions and closed 121 in Q2 2022.
- Glenmede Trust's portfolio value fell 16% quarter-over-quarter to $17.1B.
Based on Glenmede Trust's 13F filing for Q2 2022, filed 15 Aug 2022.